This Astonishing Healthcare podcast episode features Bridget Mulvenna, who joins us in the studio again for an insightful discussion about addressing data access hurdles and utilizing pharmacy claims data. Building on her previous episodes, we dig into the "how" here - how can plan sponsors get their data, analyze it, and use it to make more informed decisions. It's encouraging that things are getting a little better out there, but data transparency and sharing remain top concerns for channel partners and plan fiduciaries alike; everyone is trying to understand what's driving costs higher within their plans (aside from GLP-1s, of course)!
What data do you need? Who can/should do the analysis? What do contract definitions have to do with this? We cover it all, offering practical suggestions to hold partners accountable based on Bridget's experience.
Related Content
For more information about Capital Rx and this episode, please visit Capital Rx Insights.
